SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-054736
Filing Date
2018-10-10
Accepted
2018-10-10 19:30:23
Documents
2
Period of Report
2018-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4032
2 POA DOCUMENT poa.txt EX-24.3_813288 3051
  Complete submission text file 0001209191-18-054736.txt   8403
Mailing Address 601 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Humer Franz B (Reporting) CIK: 0001548072 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38693 | Film No.: 181117059

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)